Moritz F Sinner1, Jonathan P Piccini2,3, Melissa A Greiner2, Allan J Walkey4, Erin R Wallace5, Susan R Heckbert5, Emelia J Benjamin4,6, Lesley H Curtis2,3. 1. Department of Medicine I, University Hospital Munich, Campus Grosshadern, Ludwig Maximilians University, Munich, Germany. 2. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. 3. Department of Medicine, Duke University School of Medicine, Durham, North Carolina. 4. Department of Medicine, Boston University School of Medicine, Boston, Massachusetts. 5. Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington. 6. Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
Abstract
BACKGROUND: Catheter ablation for atrial fibrillation is used increasingly in older patients, yet the risks and benefits are not completely understood. With such uncertainty, local medical opinion may influence catheter ablation use. METHODS: In a 100% sample of Medicare beneficiaries ≥65 years who underwent catheter ablation for atrial fibrillation between January 1, 2007, and December 31, 2009, we investigated variation in use by hospital referral region (HRR) for 20,176 catheter ablation procedures. RESULTS: Across 274 HRRs, median age was 71.2 years (interquartile range 70.5-71.8), a median of 98% of patients were white, and a median of 39% of patients were women. The median age-standardized prevalence of atrial fibrillation was 77.1 (69.4-84.2) per 1,000 beneficiaries; the median rate of catheter ablation was 3.5 (2.4-4.9) per 1,000 beneficiaries. We found no significant associations between the rate of catheter ablation and prevalence of atrial fibrillation (P = .99), end-of-life Medicare expenditures per capita (P = .09), or concentration of cardiologists (P = .45) but a slight association with Medicare expenditures per capita (linear regression estimate 0.016; 95% CI 0.001-0.031; P = .04). Examined HRR characteristics explained only 2% of the variation in HRR-level rates of catheter ablation (model R(2) = 0.016). CONCLUSION: The rate of catheter ablation for atrial fibrillation in older patients was low, varied substantially by region, and was not associated with the prevalence of atrial fibrillation, the availability of cardiologists, or end-of-life resource use and was only slightly associated with overall Medicare expenditures per capita.
BACKGROUND: Catheter ablation for atrial fibrillation is used increasingly in older patients, yet the risks and benefits are not completely understood. With such uncertainty, local medical opinion may influence catheter ablation use. METHODS: In a 100% sample of Medicare beneficiaries ≥65 years who underwent catheter ablation for atrial fibrillation between January 1, 2007, and December 31, 2009, we investigated variation in use by hospital referral region (HRR) for 20,176 catheter ablation procedures. RESULTS: Across 274 HRRs, median age was 71.2 years (interquartile range 70.5-71.8), a median of 98% of patients were white, and a median of 39% of patients were women. The median age-standardized prevalence of atrial fibrillation was 77.1 (69.4-84.2) per 1,000 beneficiaries; the median rate of catheter ablation was 3.5 (2.4-4.9) per 1,000 beneficiaries. We found no significant associations between the rate of catheter ablation and prevalence of atrial fibrillation (P = .99), end-of-life Medicare expenditures per capita (P = .09), or concentration of cardiologists (P = .45) but a slight association with Medicare expenditures per capita (linear regression estimate 0.016; 95% CI 0.001-0.031; P = .04). Examined HRR characteristics explained only 2% of the variation in HRR-level rates of catheter ablation (model R(2) = 0.016). CONCLUSION: The rate of catheter ablation for atrial fibrillation in older patients was low, varied substantially by region, and was not associated with the prevalence of atrial fibrillation, the availability of cardiologists, or end-of-life resource use and was only slightly associated with overall Medicare expenditures per capita.
Authors: Thomas F Deering; Walter K Clair; M Craig Delaughter; Westby G Fisher; Ann C Garlitski; Bruce L Wilkoff; Anne M Gillis Journal: Heart Rhythm Date: 2010-07-23 Impact factor: 6.343
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: Manesh R Patel; Melissa A Greiner; Lisa D DiMartino; Kevin A Schulman; Pamela W Duncan; David B Matchar; Lesley H Curtis Journal: Arch Intern Med Date: 2010-07-26
Authors: Jonathan P Piccini; Renato D Lopes; Melissa H Kong; Vic Hasselblad; Kevin Jackson; Sana M Al-Khatib Journal: Circ Arrhythm Electrophysiol Date: 2009-12
Authors: Denise L Anthony; M Brooke Herndon; Patricia M Gallagher; Amber E Barnato; Julie P W Bynum; Daniel J Gottlieb; Elliott S Fisher; Jonathan S Skinner Journal: Health Aff (Millwood) Date: 2009 May-Jun Impact factor: 6.301
Authors: A Shah; D Prieto-Alhambra; S Hawley; A Delmestri; J Lippett; C Cooper; A Judge; M K Javaid Journal: Osteoporos Int Date: 2016-11-03 Impact factor: 4.507
Authors: Frank Olsen; Bård Uleberg; Bjarne K Jacobsen; Ivar Heuch; Pål M Tande; Einar Bugge; Lise Balteskard Journal: BMC Public Health Date: 2022-02-14 Impact factor: 4.135